Healing & Recovery

TB-500 vs BPC-157 — Which Recovery Peptide for Which Study?

TB-500 and BPC-157 compared for recovery research — pathways, targets, and when to combine.

Research use only. All products discussed are sold strictly for laboratory research. Not for human or animal consumption, diagnosis, cure, or treatment. No dosing or administration guidance is provided.

Both TB-500 and BPC-157 dominate recovery-peptide research and act through complementary pathways.

Side-by-side

| | BPC-157 | TB-500 |

|---|---|---|

| Origin | Gastric juice fragment | Thymosin β-4 fragment |

| Main pathway | VEGFR2, NO system | Actin sequestration, angiogenesis |

| Strongest area | Gut, tendon, ulcer | Cardiac, muscle, wound closure |

| Half-life | Minutes | Hours |

When to combine

Blended studies use both to cover complementary pathways:

Standalone: BPC-157 5 mg, BPC-157 10 mg. Also see the BPC-157 guide and the healing category.

> For laboratory and research use only. Not for human consumption, diagnostic, or therapeutic use. All statements below summarize preclinical and academic literature.

Frequently asked questions

Which is better?

Neither universally — they target different pathways and are commonly combined.

Pre-blended?

Yes — 5 mg and 10 mg blends, plus GLOW and KLOW multi-peptide blends.

Purity?

≥99% HPLC verified.

International shipping?

Yes — express tracked worldwide.

Wholesale?

Yes — tier pricing plus custom quote.

Human use?

No — research only.

Research use only. All products discussed are sold strictly for laboratory research. Not for human or animal consumption, diagnosis, cure, or treatment. No dosing or administration guidance is provided.

← Back to blog